This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Accretive Health Reports Third Quarter 2012 Financial Results

Accretive Health, Inc. (NYSE: AH), today reported financial results for the quarter ended September 30, 2012.

Highlights for Third Quarter 2012
  • New Quality and Total Cost of Care Agreement with Cancer Clinics of Excellence.
  • PCARR, as of today, $907 million to $925 million.
  • Net services revenue of $223.1 million as compared to $218.9 million in the third quarter of 2011.
  • Net income of $2.8 million as compared to $7.3 million in the third quarter of 2011.
  • Diluted earnings per share of $0.03 as compared to $0.07 in the third quarter of 2011.
  • Non-GAAP adjusted EBITDA of $15.4 million as compared to $21.7 million in the third quarter of 2011.
  • Non-GAAP adjusted diluted earnings per share of $0.06 as compared to $0.11 in the third quarter of 2011.

Mary Tolan, Accretive Health's Founder and Chief Executive Officer, said, “We recently announced our strategic relationship with Cancer Centers of Excellence to develop an innovative end-to-end oncology care management offering focused on enabling their member physician practices to deliver better outcomes for patients while containing costs. We are delighted to partner with a leading healthcare organization in this innovative effort.”

“The expansion of our service offerings with the launch of our new Intra-Stay Quality solution, and the signing of the inaugural client, creates a strategic collaboration that will enable our client to improve the overall patient experience and the quality of care while reducing inefficiencies and redundancies in healthcare costs.”

“PCARR, our projected contracted annual revenue run rate, increased by 26 percent at the end of the third quarter of 2012 compared with the third quarter of 2011, excluding PCARR associated with terminated client contracts associated with our litigation settlement in Minnesota in July of this year. Going forward our pipeline is strong and we are currently in conversations with several large health systems. We believe this is a clear indication that healthcare innovators recognize the value we can contribute toward helping them fulfill their missions of bringing quality and affordable care to the communities they serve.”

1 of 10

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,619.51 +23.16 0.13%
S&P 500 2,063.12 +5.48 0.27%
NASDAQ 4,986.8670 +28.3990 0.57%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs